Get involved

Claim

Opening the claim…

The four positive controls come out as the trials' own reports lead one to expect: reports of serious COVID-19 in COVID-19 vaccine trials are lower on vaccine (ratio 0.29, 95% CI 0.18 to 0.47), as are serious dengue in dengue vaccine trials (0.55, 0.33 to 0.94) and serious gastroenteritis in rotavirus vaccine trials (0.72, 0.63 to 0.83), and injection-site pain is more frequent against inert placebo (3.38, 2.67 to 4.28); and the three negative controls don't differ: fractures in trials of adults aged 50 and over (0.92, 0.84 to 1.02), injuries, poisonings and procedural complications (1.01, 0.96 to 1.06), and neoplasms (1.01, 0.97 to 1.06). · sciencejournal.ai